AssetMark Inc’s OptimizeRx OPRX Stock Holding History

AssetMark Inc’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-92	Closed	-$1.35K	–	1647
2023 Q1	$1.35K	Buy	+92	New	+$1.54K	﹤0.01%	1429

Other funds holding OPRX

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

AssetMark Inc's OPRX Position: Q2 2023 in Review

AssetMark Inc sold out of OptimizeRx (OPRX) in Q2 2023, closing a stake of 92 shares — an estimated $1.35K sold.

AssetMark Inc first reported a position in OPRX in Q1 2023 and held it in 1 quarter. The position peaked at $1.35K in Q1 2023. 102 funds tracked by Wall St. Rank hold OPRX as of Q2 2023.

AssetMark Inc reported no remaining OptimizeRx position as of Q2 2023 after selling out during the quarter.
AssetMark Inc sold 92 OptimizeRx shares in Q2 2023, an estimated $1.35K.
AssetMark Inc first reported a position in OptimizeRx in Q1 2023 and held it in 1 quarter.
AssetMark Inc's OptimizeRx position peaked at $1.35K in Q1 2023.
102 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2023.

Based on AssetMark Inc's 13F filing for Q2 2023, filed 11 Aug 2023.